Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2007-04-03

AUTHORS

A Sultana, C Tudur Smith, D Cunningham, N Starling, D Tait, J P Neoptolemos, P Ghaneh

ABSTRACT

There is no consensus on the management of locally advanced pancreatic cancer, with either chemotherapy or combined modality approaches being employed (Maheshwari and Moser, 2005). No published meta-analysis (Fung et al, 2003; Banu et al, 2005; Liang, 2005; Bria et al, 2006; Milella et al, 2006) has included randomised controlled trials employing radiation therapy. The aim of this systematic review was to compare the following: (i) chemoradiation followed by chemotherapy (combined modality therapy) vs best supportive care (ii) radiotherapy vs chemoradiation (iii) radiotherapy vs combined modality therapy (iv) chemotherapy vs combined modality therapy (v) 5FU-based combined modality treatment vs another-agent-based combined modality therapy. Relevant randomised controlled trials were identified by searching databases, trial registers and conference proceedings. The primary end point was overall survival and secondary end points were progression-free survival/time-to-progression, response rate and adverse events. Survival data were summarised using hazard ratio (HR) and response-rate/adverse-event data with relative risk. Eleven trials involving 794 patients met the inclusion criteria. Length of survival with chemoradiation was increased compared with radiotherapy alone (two trials, 168 patients, HR 0.69; 95% confidence interval (CI) 0.51–0.94), but chemoradiation followed by chemotherapy did not lead to a survival advantage over chemotherapy alone (two trials, 134 patients, HR 0.79; CI 0.32–1.95). Meta-analyses could not be performed for the other comparisons. A survival benefit was demonstrated for chemoradiation over radiotherapy alone. Chemoradiation followed by chemotherapy did not demonstrate any survival advantage over chemotherapy alone, but important clinical differences cannot be ruled out due to the wide CI. More... »

PAGES

1183-1190

References to SciGraph publications

  • 1995-08. Review of survival analyses published in cancer journals in BRITISH JOURNAL OF CANCER
  • 1999-01. Preoperative Chemoradiation for Patients With Locally Advanced Adenocarcinoma of the Pancreas in ANNALS OF SURGICAL ONCOLOGY
  • 2005-08. Current management of locally advanced pancreatic cancer in NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/sj.bjc.6603719

    DOI

    http://dx.doi.org/10.1038/sj.bjc.6603719

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1019012220

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/17406358


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Oncology and Carcinogenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Combined Modality Therapy", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Meta-Analysis as Topic", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Pancreatic Neoplasms", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Randomized Controlled Trials as Topic", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Division of Surgery and Oncology, School of Cancer Studies, University of Liverpool, 5th Floor-UCD Building, Daulby Street, L69 3GA, Liverpool, UK", 
              "id": "http://www.grid.ac/institutes/grid.10025.36", 
              "name": [
                "Division of Surgery and Oncology, School of Cancer Studies, University of Liverpool, 5th Floor-UCD Building, Daulby Street, L69 3GA, Liverpool, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Sultana", 
            "givenName": "A", 
            "id": "sg:person.01246775112.38", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01246775112.38"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Centre for Medical Statistics and Health Evaluation, University of Liverpool, Shelley's Cottage, Brownlow Street, L69 3GS, Liverpool, UK", 
              "id": "http://www.grid.ac/institutes/grid.10025.36", 
              "name": [
                "Centre for Medical Statistics and Health Evaluation, University of Liverpool, Shelley's Cottage, Brownlow Street, L69 3GS, Liverpool, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Tudur Smith", 
            "givenName": "C", 
            "id": "sg:person.01261374732.97", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01261374732.97"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Medicine, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK", 
              "id": "http://www.grid.ac/institutes/grid.424926.f", 
              "name": [
                "Department of Medicine, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Cunningham", 
            "givenName": "D", 
            "id": "sg:person.01320161130.16", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01320161130.16"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Medicine, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK", 
              "id": "http://www.grid.ac/institutes/grid.424926.f", 
              "name": [
                "Department of Medicine, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Starling", 
            "givenName": "N", 
            "id": "sg:person.01136565472.17", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01136565472.17"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Clinical Oncology, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK", 
              "id": "http://www.grid.ac/institutes/grid.424926.f", 
              "name": [
                "Department of Clinical Oncology, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Tait", 
            "givenName": "D", 
            "id": "sg:person.0753037103.30", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753037103.30"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Surgery and Oncology, School of Cancer Studies, University of Liverpool, 5th Floor-UCD Building, Daulby Street, L69 3GA, Liverpool, UK", 
              "id": "http://www.grid.ac/institutes/grid.10025.36", 
              "name": [
                "Division of Surgery and Oncology, School of Cancer Studies, University of Liverpool, 5th Floor-UCD Building, Daulby Street, L69 3GA, Liverpool, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Neoptolemos", 
            "givenName": "J P", 
            "id": "sg:person.012537142122.12", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012537142122.12"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Surgery and Oncology, School of Cancer Studies, University of Liverpool, 5th Floor-UCD Building, Daulby Street, L69 3GA, Liverpool, UK", 
              "id": "http://www.grid.ac/institutes/grid.10025.36", 
              "name": [
                "Division of Surgery and Oncology, School of Cancer Studies, University of Liverpool, 5th Floor-UCD Building, Daulby Street, L69 3GA, Liverpool, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Ghaneh", 
            "givenName": "P", 
            "id": "sg:person.07372440237.86", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07372440237.86"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/ncpgasthep0240", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1050640294", 
              "https://doi.org/10.1038/ncpgasthep0240"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/bjc.1995.364", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1032504390", 
              "https://doi.org/10.1038/bjc.1995.364"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10434-999-0038-z", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1022001684", 
              "https://doi.org/10.1007/s10434-999-0038-z"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2007-04-03", 
        "datePublishedReg": "2007-04-03", 
        "description": "There is no consensus on the management of locally advanced pancreatic cancer, with either chemotherapy or combined modality approaches being employed (Maheshwari and Moser, 2005). No published meta-analysis (Fung et al, 2003; Banu et al, 2005; Liang, 2005; Bria et al, 2006; Milella et al, 2006) has included randomised controlled trials employing radiation therapy. The aim of this systematic review was to compare the following: (i) chemoradiation followed by chemotherapy (combined modality therapy) vs best supportive care (ii) radiotherapy vs chemoradiation (iii) radiotherapy vs combined modality therapy (iv) chemotherapy vs combined modality therapy (v) 5FU-based combined modality treatment vs another-agent-based combined modality therapy. Relevant randomised controlled trials were identified by searching databases, trial registers and conference proceedings. The primary end point was overall survival and secondary end points were progression-free survival/time-to-progression, response rate and adverse events. Survival data were summarised using hazard ratio (HR) and response-rate/adverse-event data with relative risk. Eleven trials involving 794 patients met the inclusion criteria. Length of survival with chemoradiation was increased compared with radiotherapy alone (two trials, 168 patients, HR 0.69; 95% confidence interval (CI) 0.51\u20130.94), but chemoradiation followed by chemotherapy did not lead to a survival advantage over chemotherapy alone (two trials, 134 patients, HR 0.79; CI 0.32\u20131.95). Meta-analyses could not be performed for the other comparisons. A survival benefit was demonstrated for chemoradiation over radiotherapy alone. Chemoradiation followed by chemotherapy did not demonstrate any survival advantage over chemotherapy alone, but important clinical differences cannot be ruled out due to the wide CI.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/sj.bjc.6603719", 
        "inLanguage": "en", 
        "isAccessibleForFree": true, 
        "isPartOf": [
          {
            "id": "sg:journal.1017082", 
            "issn": [
              "0007-0920", 
              "1532-1827"
            ], 
            "name": "British Journal of Cancer", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "8", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "96"
          }
        ], 
        "keywords": [
          "advanced pancreatic cancer", 
          "modality therapy", 
          "hazard ratio", 
          "pancreatic cancer", 
          "survival advantage", 
          "progression-free survival/time", 
          "systematic review", 
          "end point", 
          "primary end point", 
          "Secondary end points", 
          "important clinical differences", 
          "length of survival", 
          "adverse event data", 
          "care radiotherapy", 
          "Trials Register", 
          "overall survival", 
          "adverse events", 
          "survival benefit", 
          "modality treatment", 
          "clinical differences", 
          "wide CIs", 
          "relative risk", 
          "modality approach", 
          "chemoradiation", 
          "inclusion criteria", 
          "radiation therapy", 
          "chemotherapy", 
          "response rate", 
          "radiotherapy", 
          "therapy", 
          "survival data", 
          "trials", 
          "conference proceedings", 
          "cancer", 
          "survival", 
          "patients", 
          "review", 
          "progression", 
          "management", 
          "treatment", 
          "risk", 
          "Register", 
          "aim", 
          "radiation/", 
          "data", 
          "differences", 
          "consensus", 
          "database", 
          "criteria", 
          "benefits", 
          "rate", 
          "events", 
          "cis", 
          "Relevant", 
          "ratio", 
          "time", 
          "point", 
          "comparison", 
          "length", 
          "proceedings", 
          "advantages", 
          "approach"
        ], 
        "name": "Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy", 
        "pagination": "1183-1190", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1019012220"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/sj.bjc.6603719"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "17406358"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/sj.bjc.6603719", 
          "https://app.dimensions.ai/details/publication/pub.1019012220"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-06-01T22:06", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220601/entities/gbq_results/article/article_443.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/sj.bjc.6603719"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6603719'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6603719'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6603719'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6603719'


     

    This table displays all metadata directly associated to this object as RDF triples.

    205 TRIPLES      22 PREDICATES      96 URIs      85 LITERALS      12 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/sj.bjc.6603719 schema:about N05418937ec734612aa67148d38e26df7
    2 N4c635050157443559d75b153d64e3e59
    3 Nd42619e9b8c34581bd7f89e5810b4e3d
    4 Nd4da9499cd9645e78dd48275bbae3e0b
    5 Nf59bb687dcb24a3aa9b994a1beb099ec
    6 anzsrc-for:11
    7 anzsrc-for:1112
    8 schema:author N242ffefcd67f40b1b0623ac2f2284215
    9 schema:citation sg:pub.10.1007/s10434-999-0038-z
    10 sg:pub.10.1038/bjc.1995.364
    11 sg:pub.10.1038/ncpgasthep0240
    12 schema:datePublished 2007-04-03
    13 schema:datePublishedReg 2007-04-03
    14 schema:description There is no consensus on the management of locally advanced pancreatic cancer, with either chemotherapy or combined modality approaches being employed (Maheshwari and Moser, 2005). No published meta-analysis (Fung et al, 2003; Banu et al, 2005; Liang, 2005; Bria et al, 2006; Milella et al, 2006) has included randomised controlled trials employing radiation therapy. The aim of this systematic review was to compare the following: (i) chemoradiation followed by chemotherapy (combined modality therapy) vs best supportive care (ii) radiotherapy vs chemoradiation (iii) radiotherapy vs combined modality therapy (iv) chemotherapy vs combined modality therapy (v) 5FU-based combined modality treatment vs another-agent-based combined modality therapy. Relevant randomised controlled trials were identified by searching databases, trial registers and conference proceedings. The primary end point was overall survival and secondary end points were progression-free survival/time-to-progression, response rate and adverse events. Survival data were summarised using hazard ratio (HR) and response-rate/adverse-event data with relative risk. Eleven trials involving 794 patients met the inclusion criteria. Length of survival with chemoradiation was increased compared with radiotherapy alone (two trials, 168 patients, HR 0.69; 95% confidence interval (CI) 0.51–0.94), but chemoradiation followed by chemotherapy did not lead to a survival advantage over chemotherapy alone (two trials, 134 patients, HR 0.79; CI 0.32–1.95). Meta-analyses could not be performed for the other comparisons. A survival benefit was demonstrated for chemoradiation over radiotherapy alone. Chemoradiation followed by chemotherapy did not demonstrate any survival advantage over chemotherapy alone, but important clinical differences cannot be ruled out due to the wide CI.
    15 schema:genre article
    16 schema:inLanguage en
    17 schema:isAccessibleForFree true
    18 schema:isPartOf N90659b1c99074721950e9dfda5ffa449
    19 Neee05385ea4342889814a5e819b5560d
    20 sg:journal.1017082
    21 schema:keywords Register
    22 Relevant
    23 Secondary end points
    24 Trials Register
    25 advanced pancreatic cancer
    26 advantages
    27 adverse event data
    28 adverse events
    29 aim
    30 approach
    31 benefits
    32 cancer
    33 care radiotherapy
    34 chemoradiation
    35 chemotherapy
    36 cis
    37 clinical differences
    38 comparison
    39 conference proceedings
    40 consensus
    41 criteria
    42 data
    43 database
    44 differences
    45 end point
    46 events
    47 hazard ratio
    48 important clinical differences
    49 inclusion criteria
    50 length
    51 length of survival
    52 management
    53 modality approach
    54 modality therapy
    55 modality treatment
    56 overall survival
    57 pancreatic cancer
    58 patients
    59 point
    60 primary end point
    61 proceedings
    62 progression
    63 progression-free survival/time
    64 radiation therapy
    65 radiation/
    66 radiotherapy
    67 rate
    68 ratio
    69 relative risk
    70 response rate
    71 review
    72 risk
    73 survival
    74 survival advantage
    75 survival benefit
    76 survival data
    77 systematic review
    78 therapy
    79 time
    80 treatment
    81 trials
    82 wide CIs
    83 schema:name Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy
    84 schema:pagination 1183-1190
    85 schema:productId N1abcb045cab44ed489905555880b4284
    86 N45d77a2549314d48aaf28196782d22dd
    87 Nc644450a76c04348a9d07d586f859e43
    88 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019012220
    89 https://doi.org/10.1038/sj.bjc.6603719
    90 schema:sdDatePublished 2022-06-01T22:06
    91 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    92 schema:sdPublisher Ncb455bb44bfb433bafd9c72c05547a25
    93 schema:url https://doi.org/10.1038/sj.bjc.6603719
    94 sgo:license sg:explorer/license/
    95 sgo:sdDataset articles
    96 rdf:type schema:ScholarlyArticle
    97 N05418937ec734612aa67148d38e26df7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    98 schema:name Combined Modality Therapy
    99 rdf:type schema:DefinedTerm
    100 N1abcb045cab44ed489905555880b4284 schema:name doi
    101 schema:value 10.1038/sj.bjc.6603719
    102 rdf:type schema:PropertyValue
    103 N242ffefcd67f40b1b0623ac2f2284215 rdf:first sg:person.01246775112.38
    104 rdf:rest N251347951f7a48b79d23f7eb7f5bb5f3
    105 N251347951f7a48b79d23f7eb7f5bb5f3 rdf:first sg:person.01261374732.97
    106 rdf:rest N8c596cdeee9f45f899b1759de6aace1b
    107 N3196037d45d942d898dbe8666de4897e rdf:first sg:person.01136565472.17
    108 rdf:rest Nd35e01d710cc4f33b3497fed28d3f949
    109 N3e084061aca34d939ed331d0e7a4f443 rdf:first sg:person.012537142122.12
    110 rdf:rest Nbc61b85fc9604568af6faa1fa13ddd32
    111 N45d77a2549314d48aaf28196782d22dd schema:name dimensions_id
    112 schema:value pub.1019012220
    113 rdf:type schema:PropertyValue
    114 N4c635050157443559d75b153d64e3e59 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    115 schema:name Humans
    116 rdf:type schema:DefinedTerm
    117 N8c596cdeee9f45f899b1759de6aace1b rdf:first sg:person.01320161130.16
    118 rdf:rest N3196037d45d942d898dbe8666de4897e
    119 N90659b1c99074721950e9dfda5ffa449 schema:issueNumber 8
    120 rdf:type schema:PublicationIssue
    121 Nbc61b85fc9604568af6faa1fa13ddd32 rdf:first sg:person.07372440237.86
    122 rdf:rest rdf:nil
    123 Nc644450a76c04348a9d07d586f859e43 schema:name pubmed_id
    124 schema:value 17406358
    125 rdf:type schema:PropertyValue
    126 Ncb455bb44bfb433bafd9c72c05547a25 schema:name Springer Nature - SN SciGraph project
    127 rdf:type schema:Organization
    128 Nd35e01d710cc4f33b3497fed28d3f949 rdf:first sg:person.0753037103.30
    129 rdf:rest N3e084061aca34d939ed331d0e7a4f443
    130 Nd42619e9b8c34581bd7f89e5810b4e3d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    131 schema:name Meta-Analysis as Topic
    132 rdf:type schema:DefinedTerm
    133 Nd4da9499cd9645e78dd48275bbae3e0b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    134 schema:name Pancreatic Neoplasms
    135 rdf:type schema:DefinedTerm
    136 Neee05385ea4342889814a5e819b5560d schema:volumeNumber 96
    137 rdf:type schema:PublicationVolume
    138 Nf59bb687dcb24a3aa9b994a1beb099ec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    139 schema:name Randomized Controlled Trials as Topic
    140 rdf:type schema:DefinedTerm
    141 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    142 schema:name Medical and Health Sciences
    143 rdf:type schema:DefinedTerm
    144 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
    145 schema:name Oncology and Carcinogenesis
    146 rdf:type schema:DefinedTerm
    147 sg:journal.1017082 schema:issn 0007-0920
    148 1532-1827
    149 schema:name British Journal of Cancer
    150 schema:publisher Springer Nature
    151 rdf:type schema:Periodical
    152 sg:person.01136565472.17 schema:affiliation grid-institutes:grid.424926.f
    153 schema:familyName Starling
    154 schema:givenName N
    155 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01136565472.17
    156 rdf:type schema:Person
    157 sg:person.01246775112.38 schema:affiliation grid-institutes:grid.10025.36
    158 schema:familyName Sultana
    159 schema:givenName A
    160 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01246775112.38
    161 rdf:type schema:Person
    162 sg:person.012537142122.12 schema:affiliation grid-institutes:grid.10025.36
    163 schema:familyName Neoptolemos
    164 schema:givenName J P
    165 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012537142122.12
    166 rdf:type schema:Person
    167 sg:person.01261374732.97 schema:affiliation grid-institutes:grid.10025.36
    168 schema:familyName Tudur Smith
    169 schema:givenName C
    170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01261374732.97
    171 rdf:type schema:Person
    172 sg:person.01320161130.16 schema:affiliation grid-institutes:grid.424926.f
    173 schema:familyName Cunningham
    174 schema:givenName D
    175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01320161130.16
    176 rdf:type schema:Person
    177 sg:person.07372440237.86 schema:affiliation grid-institutes:grid.10025.36
    178 schema:familyName Ghaneh
    179 schema:givenName P
    180 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07372440237.86
    181 rdf:type schema:Person
    182 sg:person.0753037103.30 schema:affiliation grid-institutes:grid.424926.f
    183 schema:familyName Tait
    184 schema:givenName D
    185 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753037103.30
    186 rdf:type schema:Person
    187 sg:pub.10.1007/s10434-999-0038-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1022001684
    188 https://doi.org/10.1007/s10434-999-0038-z
    189 rdf:type schema:CreativeWork
    190 sg:pub.10.1038/bjc.1995.364 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032504390
    191 https://doi.org/10.1038/bjc.1995.364
    192 rdf:type schema:CreativeWork
    193 sg:pub.10.1038/ncpgasthep0240 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050640294
    194 https://doi.org/10.1038/ncpgasthep0240
    195 rdf:type schema:CreativeWork
    196 grid-institutes:grid.10025.36 schema:alternateName Centre for Medical Statistics and Health Evaluation, University of Liverpool, Shelley's Cottage, Brownlow Street, L69 3GS, Liverpool, UK
    197 Division of Surgery and Oncology, School of Cancer Studies, University of Liverpool, 5th Floor-UCD Building, Daulby Street, L69 3GA, Liverpool, UK
    198 schema:name Centre for Medical Statistics and Health Evaluation, University of Liverpool, Shelley's Cottage, Brownlow Street, L69 3GS, Liverpool, UK
    199 Division of Surgery and Oncology, School of Cancer Studies, University of Liverpool, 5th Floor-UCD Building, Daulby Street, L69 3GA, Liverpool, UK
    200 rdf:type schema:Organization
    201 grid-institutes:grid.424926.f schema:alternateName Department of Clinical Oncology, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK
    202 Department of Medicine, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK
    203 schema:name Department of Clinical Oncology, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK
    204 Department of Medicine, Royal Marsden Hospital, Downs Road, SM2 5PT, Sutton, Surrey, UK
    205 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...